Bay City Capital LLC

750 Battery Street, Suite 400,
San Francisco, California 94111
United States,
(415)676-3830
www.baycitycapital.com
lcarnot@baycitycapital.com

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.


M&A Summary

Buy vs Sell

Top M&A Advisors

Join Mergr to view the latest updates and news from San Francisco-based Bay City Capital.

Bay City Capital’s most common sectors for investment are life science (68%) and medical products (17%). The Firm’s most common investment types include venture (63%) and buyout (lbo, mbo, mbi) (24%). In total, Bay City Capital has invested in 13 US states and 4 different countries. Its largest (disclosed) acquisition occurred in 2009 when it acquired Epizyme for $32M.

In the last 3 years, Bay City Capital has exited 6 companies. The Firm’s most common exit type is trade sale (56%). Bay City Capital’s largest (disclosed) exit occurred in 2007 when it sold Reliant Pharmaceuticals for $1.7B.

Join Mergr to view Bay City Capital’s full profile and discover more large private equity firms just like it.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.